• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

OTC drugs

Daiichi Sankyo
Pharma

Daiichi Sankyo plots $1.5B consumer health unit sale to Suntory

With its focus increasingly tied to its cancer meds, Daiichi Sankyo is following several of its peers in splitting from its consumer health business.
Fraiser Kansteiner Apr 15, 2026 3:22pm
Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Bayer inks IPG deal to consolidate consumer health marketing

Oct 1, 2025 8:30am
decongestants

FDA wants to end sale of oral phenylephrine as OTC decongestant

Nov 8, 2024 10:32am
Viatris

Viatris to haul in $3.37B with 3 business divestures

Oct 2, 2023 4:49pm
Cold and flu pills

FDA panel votes to end OTC use of common decongestant drug

Sep 13, 2023 11:00am
visual showing four 100 bills

Formulated Solutions in deal to buy former Merck, Bayer facility

Dec 20, 2022 9:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings